BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11099105)

  • 1. Treatment of hepatitis C infection.
    Robinson JL
    Pediatr Infect Dis J; 2000 Nov; 19(11):1114. PubMed ID: 11099105
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of interferon treatment for hepatitis C.
    Henley E
    JAMA; 1999 Jun; 281(22):2083; author reply 2084. PubMed ID: 10367809
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of interferon treatment for hepatitis C.
    van Leeuwen DJ
    JAMA; 1999 Jun; 281(22):2083-4. PubMed ID: 10367810
    [No Abstract]   [Full Text] [Related]  

  • 4. [Economic evaluation of combined therapy in chronic hepatitis C].
    Casado MA; Buti M; Fosbrook L; Esteban R
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():57-62. PubMed ID: 11968346
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cost-effectiveness of antiviral therapy for chronic hepatitis C patients in prevention of hepatocellular cancer ].
    Yoshida H; Tateishi R; Omata M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):511-4. PubMed ID: 15359852
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness of treatment for chronic hepatitis C.
    Koff RS
    J Hepatol; 1999; 31 Suppl 1():255-8. PubMed ID: 10622598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and cost-effectiveness of consensus interferon monotherapy with high-dose induction for hepatitis C patients with genotype 2.
    Iwasaki Y; Tanaka H; Ikeada H; Okamoto R; Araki Y; Yabushita K; Kobashi H; Kariyama K; Kawaguchi M; Takaguchi K; Sakata T; Ando M; Sakaguchi K; Aoki N; Shiratori Y
    Scand J Gastroenterol; 2011 Jan; 46(1):79-90. PubMed ID: 20822376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness analysis of different strategies of management of chronic hepatitis C infection in children.
    Sinha M; Das A
    Pediatr Infect Dis J; 2000 Jan; 19(1):23-30. PubMed ID: 10643846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interferons and chronic hepatitis C treatment].
    Cai DC; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2007 Nov; 15(11):847-8. PubMed ID: 18073070
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti-viral therapy of type C chronic hepatitis. 2. Progression of type C chronic hepatitis and resistance to treatment. 2) Participation of host factors].
    Ikejima K; Yaginuma R; Watanabe S
    Nihon Naika Gakkai Zasshi; 2008 Jan; 97(1):69-74. PubMed ID: 18360973
    [No Abstract]   [Full Text] [Related]  

  • 11. [Interferon treatment of chronic hepatitis C viral hepatitis patients with normal transaminases].
    Remy AJ; Blanc P
    Gastroenterol Clin Biol; 1998; 22(8-9):748-9. PubMed ID: 9823572
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy forecast on interferon in the treatment of chronic viral hepatitis].
    Mei YY; Gao ZL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):8-9. PubMed ID: 21272450
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of treatment non responders in chronic hepatitis C.
    Poynard T
    Med J Malaysia; 2005 Jul; 60 Suppl B():77-9. PubMed ID: 16108180
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anti-viral therapy of type C chronic hepatitis. 2. Progression of type C chronic hepatitis and resistance to treatment. 1) From a viewpoint of viral mutation].
    Sakamoto N
    Nihon Naika Gakkai Zasshi; 2008 Jan; 97(1):64-8. PubMed ID: 18360972
    [No Abstract]   [Full Text] [Related]  

  • 15. Schistosomiasis and antiviral treatment of chronic hepatitis C.
    Di Marco V; Capra M; Gagliardotto F; Ferraro D; Di Stefano R
    Hepatology; 2001 Oct; 34(4 Pt 1):850-1. PubMed ID: 11584389
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term outcomes of interferon therapy for chronic hepatitis].
    Dou XG; Zhao LR
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):10. PubMed ID: 21272451
    [No Abstract]   [Full Text] [Related]  

  • 17. [Predicting factors in the efficacy of interferon treatment in chronic hepatitis C].
    Rodríguez Agulló JL
    An Med Interna; 2001 Jul; 18(7):349-50. PubMed ID: 11534417
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chronic hepatitis C from the viewpoint of the patients. There are many causes for the quality of life of patients with chronic hepatitis C to be impaired. But there also exist many possibilities to change it].
    MMW Fortschr Med; 2002 Nov; 144(48):59. PubMed ID: 12532549
    [No Abstract]   [Full Text] [Related]  

  • 19. [Situation and prospect of TCM treatment of chronic hepatitis C].
    Wang LT
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Jan; 28(1):11-2. PubMed ID: 18418960
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of chronic hepatitis C in patients without previous treatment].
    Dehesa Violante M
    Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S42-4. PubMed ID: 12712852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.